Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 3 Insider Initial Statement of Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Regulation FD disclosure
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations · Other events
  15. S-8 POS Other Post-effective Amendment
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Regulation FD disclosure · Other events
  19. 8-K Event Regulation FD disclosure · Other events
  20. 8-K Event Shareholder vote results

Page 13 of 23 · 454 filings